Status:
UNKNOWN
Conservative Treatment of Gastrointestinal Fistulas by Endoscopic Injection of tSVFem
Lead Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions:
Gastrointestinal Fistula
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Gastrointestinal (GI) fistula is a complex condition with high mortality and requiring a multidisciplinary management. The aim of this study is to exploit the regenerative-tissue capacities of autolo...
Detailed Description
Gastrointestinal fistula may be a life-threatening condition caused by several types of injuries (iatrogenic, traumatic, post-operative), requiring complex and multidisciplinary management. To date, n...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- • Patients affected by GI fistulas, not fit for surgical treatments of after failure of conventional conservative treatments
- Exclusion Criteria:
- Enteroenteric fistulas
- Patients who do not sign informed consent form
Exclusion
Key Trial Info
Start Date :
November 2 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 10 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04670276
Start Date
November 2 2020
End Date
April 10 2022
Last Update
December 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondazione Policlinico Agostino Gemelli IRCCS
Roma, Italy, 00168